These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23605155)

  • 21. Risk factors for nonadherence with Pap testing in HIV-infected women.
    Baranoski AS; Horsburgh CR; Cupples LA; Aschengrau A; Stier EA
    J Womens Health (Larchmt); 2011 Nov; 20(11):1635-43. PubMed ID: 21879883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cancer screening after 50: near extinction?
    Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Socioeconomic determinants of cervical cancer screening in Latin America.
    Soneji S; Fukui N
    Rev Panam Salud Publica; 2013 Mar; 33(3):174-82. PubMed ID: 23698136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of cervical cancer screening of HIV-infected women in the United States.
    Oster AM; Sullivan PS; Blair JM
    J Acquir Immune Defic Syndr; 2009 Aug; 51(4):430-6. PubMed ID: 19474756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of early rescreening in the National Cervical Screening Program, Australia.
    Mitchell H; Hocking J
    Aust N Z J Public Health; 2001 Aug; 25(4):334-8. PubMed ID: 11529614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
    MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
    J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cancer screening among Lebanese women.
    Bou-Orm IR; Sakr RE; Adib SM
    Rev Epidemiol Sante Publique; 2018 Feb; 66(1):1-6. PubMed ID: 29249573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
    Al Rifai R; Nakamura K
    Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Maura G; Chaignot C; Weill A; Alla F; Heard I
    Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
    Guo F; Hirth JM; Berenson AB
    J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical screening uptake and its predictors among rural women in Malaysia.
    Gan DE; Dahlui M
    Singapore Med J; 2013 Mar; 54(3):163-8. PubMed ID: 23546031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers and Facilitators of Pap Testing for Women Living With HIV: A Focus Group Study.
    Jin S; Cudjoe J; Peay A; Baker D; Kunkel J; Sharps P; Han HR
    J Assoc Nurses AIDS Care; 2020; 31(2):190-196. PubMed ID: 31567730
    [No Abstract]   [Full Text] [Related]  

  • 37. The frequency of Pap smear screening in the United States.
    Sirovich BE; Welch HG
    J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
    Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
    S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge About Cervical Cancer Risk Factors and Practices of Pap Testing Among Turkish Immigrant Women in the United States.
    Uysal Toraman A; Yildirim N
    J Immigr Minor Health; 2018 Oct; 20(5):1222-1229. PubMed ID: 28929252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How Is Health Literacy Related to Pap Testing Among US Women?
    Thompson EL; Wheldon CW; Vamos CA; Griner SB; Daley EM
    J Cancer Educ; 2019 Aug; 34(4):789-795. PubMed ID: 29931455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.